Search - tctmd.com

Displaying 21 - 36 of 36

Sort: Relevancy | Date

News Daily News

Going Contrast Free in TAVI Is Safe for CKD Patients

Caitlin E. Cox

August 20, 2024

News Daily News

Both SGLT2 and GLP-1 Drugs Help Heart and Kidneys in Type 2 Diabetes

Michael O'Riordan

August 19, 2024

News Daily News

FINEARTS-HF: Topline Results Support Role for Finerenone in Mildly Reduced or Preserved EF

L.A. McKeown

August 05, 2024

News Opinion CV Team Dispatch

August 2024 Dispatch for the CV Team

L.A. McKeown

August 01, 2024

News Opinion CV Team Dispatch

July 2024 Dispatch for the CV Team

L.A. McKeown

July 01, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2024

Shelley Wood

May 31, 2024

News Daily News

FLOW: Semaglutide Scores Big in Diabetic Patients With CKD

L.A. McKeown

May 24, 2024

News Conference News SCAI 2024

CALORI: More Support for Eschewing Fasting Protocols Preprocedure

L.A. McKeown

May 02, 2024

News Conference News ACC 2024

Early Empagliflozin Doesn’t Curb HF Hospitalizations, Deaths Post-MI: EMPACT-MI

Shelley Wood

April 06, 2024

News Daily News

Patients With CKD Remain Underrepresented in Trials of CV Meds

Todd Neale

March 08, 2024

News Daily News

Semaglutide Winning Streak Continues in CKD With FLOW

Shelley Wood

March 06, 2024

Presentation CTO 2024

Risk Stratification by Ejection Fraction Within a Cohort of Patients With CKD Undergoing Ultralow-Contrast IVUS Guided PCI

Presenter: Christopher Garnett

February 03, 2024

Presentation CTO Plus 2024 Abstracts On-Demand 2024

Influence of CKD Stages on Outcomes Post-PCI in Chronic Total Occlusion Patients

Presenter: Motisola Mutema

February 02, 2024

Presentation CTO 2024

IVUS-Guided Ultralow-Contrast PCI in Patients With CKD and Diabetes: Safety Outcomes Analysis

Presenter: Christopher Garnett

February 02, 2024

News Opinion CV Team Dispatch

January 2024 Dispatch for the CV Team

L.A. McKeown

January 01, 2024

Video

» Topical Discussion

Quick Takes: Julia Colombijn on the Underrepresentation of CKD Patients in Clinical Trials

March 25, 2024

Advertisement

Going Contrast Free in TAVI Is Safe for CKD Patients

Both SGLT2 and GLP-1 Drugs Help Heart and Kidneys in Type 2 Diabetes

FINEARTS-HF: Topline Results Support Role for Finerenone in Mildly Reduced or Preserved EF

August 2024 Dispatch for the CV Team

July 2024 Dispatch for the CV Team

TCTMD’s Top 10 Most Popular Stories for May 2024

FLOW: Semaglutide Scores Big in Diabetic Patients With CKD

CALORI: More Support for Eschewing Fasting Protocols Preprocedure

Early Empagliflozin Doesn’t Curb HF Hospitalizations, Deaths Post-MI: EMPACT-MI

Patients With CKD Remain Underrepresented in Trials of CV Meds

Semaglutide Winning Streak Continues in CKD With FLOW

Risk Stratification by Ejection Fraction Within a Cohort of Patients With CKD Undergoing Ultralow-Contrast IVUS Guided PCI

Influence of CKD Stages on Outcomes Post-PCI in Chronic Total Occlusion Patients

IVUS-Guided Ultralow-Contrast PCI in Patients With CKD and Diabetes: Safety Outcomes Analysis

January 2024 Dispatch for the CV Team

Quick Takes: Julia Colombijn on the Underrepresentation of CKD Patients in Clinical Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content